Dear Dr. Renukaprasad A R, Pneumococcal disease is a global public health concern across all age groups. This disease has the potential to induce endothelial dysfunction, which can adversely impact the linings of blood vessels and potentially contribute to the instability of arterial plaque. In the context of safeguarding one's health, vaccines have consistently demonstrated their effectiveness as the most reliable defense against the development of infections associated with this condition. To learn more about pneumococcal vaccines, join this interactive LIVE session organized by Pfizer and Docplexus on September 30, 2023, at 8:30 PM IST. During this webinar, our esteemed speakers, Prof. Charles Feldman, Dr. Randeep Guleria, and Prof. Parvaiz A. Koul, will share their insights on pneumococcal vaccines for adults. Dr. Samir D. Garde will moderate the Live Q&A session.Session highlights:
- Welcome and Introduction
- Pneumococcal vaccination: Start earlier, protect longer
- Need to establish adult vaccine CoE in India
- Panel Discussion: Risk groups prioritization for pneumococcal vaccination
- Q&A and Closing
|
No comments:
Post a Comment